Cargando…

Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines

Vaccines are a key weapon against the COVID-19 pandemic caused by SARS-CoV-2. However, there are inter-individual differences in immune response to SARS-CoV-2 vaccines and genetic contributions to these differences have barely been investigated. Here, we performed genome-wide association study (GWAS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ping, Shi, Dawei, Shen, Wenlong, Shi, Shu, Guo, Xinjie, Li, Jia, Xu, Sihong, Zhang, Yan, Zhao, Zhihu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704361/ https://www.ncbi.nlm.nih.gov/pubmed/36451823 http://dx.doi.org/10.3389/fimmu.2022.1054147

Ejemplares similares

Evaluating SARS-CoV-2 antibody reactivity to natural exposure and inactivated vaccination with peptide microarrays
por: Zheng, Peiyan, et al.
Publicado: (2023)

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
por: Wu, Yufei, et al.
Publicado: (2023)

Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study
por: Li, Hong-Yan, et al.
Publicado: (2022)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Melo-González, Felipe, et al.
Publicado: (2021)

Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days
por: Xu, Qiu-Yan, et al.
Publicado: (2021)

Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years
por: Zhu, Hong-Hong, et al.
Publicado: (2023)

Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination
por: Liang, Boyun, et al.
Publicado: (2022)

Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis
por: Cao, Huanhuan, et al.
Publicado: (2023)

Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting
por: Li, Ziwei, et al.
Publicado: (2021)

Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
por: Simayi, Aidibai, et al.
Publicado: (2023)

Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao
por: Ng, Hoi Man, et al.
Publicado: (2023)

Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines
por: Duan, Binwei, et al.
Publicado: (2022)

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
por: Duarte, Luisa F., et al.
Publicado: (2021)

Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
por: Xiang, Tiandan, et al.
Publicado: (2021)

Protective antigenic epitopes revealed by immunosignatures after three doses of inactivated SARS-CoV-2 vaccine
por: Peng, Mian, et al.
Publicado: (2022)

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine
por: He, Xiaomeng, et al.
Publicado: (2023)

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer
por: Han, Yuling, et al.
Publicado: (2022)

Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study
por: Wen, Gui-Ping, et al.
Publicado: (2023)

Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine
por: Wang, Yi, et al.
Publicado: (2022)

dbGSRV: A manually curated database of genetic susceptibility to respiratory virus
por: Li, Ping, et al.
Publicado: (2022)

HLA Class II Genes HLA-DRB1, HLA-DPB1, and HLA-DQB1 Are Associated With the Antibody Response to Inactivated Japanese Encephalitis Vaccine
por: Yao, Yufeng, et al.
Publicado: (2019)

Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer
por: Song, Rui, et al.
Publicado: (2022)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
por: He, Qian, et al.
Publicado: (2022)

Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults
por: Castro, Vitória Tavares, et al.
Publicado: (2023)

Targeted screening of genetic associations with COVID-19 susceptibility and severity
por: Li, Ping, et al.
Publicado: (2022)

Neutralizing Antibody Response in Dogs and Cats Inoculated with Commercial Inactivated Rabies Vaccines
por: SHIRAISHI, Rikiya, et al.
Publicado: (2013)

Analysis of neutralizing antibodies to COVID-19 inactivated or subunit recombinant vaccines in hospitalized patients with liver dysfunction
por: Li, Hu, et al.
Publicado: (2023)

A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
por: Tokunoh, Nagisa, et al.
Publicado: (2023)

Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens
por: Vojdani, Aristo, et al.
Publicado: (2022)

Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study
por: Xu, Nani, et al.
Publicado: (2023)

In vivo structure and dynamics of the SARS-CoV-2 RNA genome
por: Zhang, Yan, et al.
Publicado: (2021)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2023)

Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
por: Klingler, Jéromine, et al.
Publicado: (2021)

Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals
por: Casian, Joseph G., et al.
Publicado: (2021)

Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
por: Markewitz, Robert, et al.
Publicado: (2022)

The associations between air pollutant exposure and neutralizing antibody titers of an inactivated SARS-CoV-2 vaccine
por: Zhang, Shaocheng, et al.
Publicado: (2021)

Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals
por: Cheng, Yandong, et al.
Publicado: (2022)

Upregulated CD8(+) MAIT cell differentiation and KLRD1 gene expression after inactivated SARS-CoV-2 vaccination identified by single-cell sequencing
por: Dou, Xiaowen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2bjpg6habqlb4ptcsgqm77drqp